The companies plan to combine Emphron's bioinformatics data-analysis capabilities and Polyclone's microarray core facility, which is being set up at the
The companies plan to combine Emphron's bioinformatics data-analysis capabilities and Polyclone's microarray core facility, which is being set up at the